← Back to Search

App-based mindfulness training for Postpartum Depression (MORPHE Trial)

N/A
Recruiting
Research Sponsored by Nina Ayala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up delivery
Awards & highlights

MORPHE Trial Summary

This trial aims to see if a mindfulness phone app called Expectful can help improve the mental health of first-time mothers with low optimism during pregnancy. The study will also look at how using the app affects

Who is the study for?
This trial is for first-time pregnant mothers with low optimism early in pregnancy (less than 20 weeks), who speak English, can consent, and have a smartphone. They must not have had a prior delivery at or beyond 20 weeks gestation.Check my eligibility
What is being tested?
The study tests the use of Expectful, a mindfulness app designed for pregnant women, against standard care to see if it improves optimism and reduces negative outcomes like cesarean deliveries and postpartum stress.See study design
What are the potential side effects?
Since this intervention involves digital mindfulness training through an app, there are no direct physical side effects. However, users may experience emotional discomfort or increased anxiety if they find engaging with the app stressful.

MORPHE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 8 week intervention period, approximately 16-28 weeks gestation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 8 week intervention period, approximately 16-28 weeks gestation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention acceptability
Percentage of participants completing the assigned mindfulness exercises
Secondary outcome measures
Cesarean delivery
Dispositional optimism
Gestational diabetes mellitus
+4 more

MORPHE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: App-based mindfulness trainingExperimental Treatment1 Intervention
App-based daily mindfulness training Standard prenatal and pregnancy care
Group II: Usual CareActive Control1 Intervention
Standard prenatal and pregnancy care

Find a Location

Who is running the clinical trial?

The Miriam HospitalOTHER
238 Previous Clinical Trials
37,375 Total Patients Enrolled
Nina AyalaLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals eligible for enrollment in this clinical research study?

"Indeed, the details on clinicaltrials.gov affirm that this research study is presently in pursuit of participants. Originally disclosed on February 20th, 2024, and last revised on March 29th, 2024, the trial aims to enroll a total of 100 patients across two designated sites."

Answered by AI

Are patients currently able to enroll in this ongoing study?

"Indeed, information available on clinicaltrials.gov confirms the active recruitment status of this particular trial. Initially shared on February 20th, 2024, and last revised on March 29th, 2024, the study aims to enroll a total of 100 participants distributed across two distinct sites."

Answered by AI

What is the primary objective that this medical study aims to achieve?

"The main focus of this research, to be assessed over an approximate 8-week intervention phase, is the acceptability of the intervention. Secondary measures encompass traumatic birth experiences categorized as binary yes or no based on perceived threat to self or infant well-being; gestational diabetes mellitus classified as a binary outcome; and postpartum post-traumatic stress symptoms gauged using the PTSD Checklist for DSM-5 (PCL-5), with scores ranging from 0 to 80 indicating severity of symptoms."

Answered by AI
~67 spots leftby Oct 2025